Evidence-based consensus guidelines on patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain
- PMID: 37001888
- PMCID: PMC10370290
- DOI: 10.1136/rapm-2022-104097
Evidence-based consensus guidelines on patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain
Abstract
Spinal cord stimulation (SCS) has demonstrated effectiveness for neuropathic pain. Unfortunately, some patients report inadequate long-term pain relief. Patient selection is emphasized for this therapy; however, the prognostic capabilities and deployment strategies of existing selection techniques, including an SCS trial, have been questioned. After approval by the Board of Directors of the American Society of Regional Anesthesia and Pain Medicine, a steering committee was formed to develop evidence-based guidelines for patient selection and the role of an SCS trial. Representatives of professional organizations with clinical expertize were invited to participate as committee members. A comprehensive literature review was carried out by the steering committee, and the results organized into narrative reports, which were circulated to all the committee members. Individual statements and recommendations within each of seven sections were formulated by the steering committee and circulated to members for voting. We used a modified Delphi method wherein drafts were circulated to each member in a blinded fashion for voting. Comments were incorporated in the subsequent revisions, which were recirculated for voting to achieve consensus. Seven sections with a total of 39 recommendations were approved with 100% consensus from all the members. Sections included definitions and terminology of SCS trial; benefits of SCS trial; screening for psychosocial characteristics; patient perceptions on SCS therapy and the use of trial; other patient predictors of SCS therapy; conduct of SCS trials; and evaluation of SCS trials including minimum criteria for success. Recommendations included that SCS trial should be performed before a definitive SCS implant except in anginal pain (grade B). All patients must be screened with an objective validated instrument for psychosocial factors, and this must include depression (grade B). Despite some limitations, a trial helps patient selection and provides patients with an opportunity to experience the therapy. These recommendations are expected to guide practicing physicians and other stakeholders and should not be mistaken as practice standards. Physicians should continue to make their best judgment based on individual patient considerations and preferences.
Keywords: back pain; chronic pain; pain management; spinal cord stimulation.
© American Society of Regional Anesthesia & Pain Medicine 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: HS, RC, JK, JR, CJW: None. SE: Received consultancy fees from Medtronic, Mainstay Medical, Boston Scientific Corp, and Saluda Medical. He has received department research funding from the National Institute of Health Research, Medtronic Ltd, and Boston Scientific. DAP: Editor for Reg Anesth Pain Med. Consulted for Avanos, Boston Scientific, Medtronic, Nevro, and SI BONE. Pain Diagnostics and Interventioal Care has received research support from Avanos, Medtronic, Nevro, Stimgenics, and Abbott. BB: Consultancy agreement with Medtronic Switzerland. Department has received unrestricted research grants from Medtronic Switzerland. EB: Consultancy agreement with Medtronic Switzerland. Department has received unrestricted research grants from Medtronic Switzerland. TD: Biohaven Pharmaceuticals (coinvestigator in clinical trial of rimegepant for trigeminal neuralgia). RD: Consultancy fees from Boston Scientific Corp, Mainstay Medical, Medtronic and Saluda Medical for work unrelated with the role and conduct of trial stimulation on spinal cord stimulation (SCS) therapy for chronic pain patients. CH: Institutional research grants from Nevro. FH: Consultancy fees from Abbott, Saluda, Salvia, Pfizer; Research grants from Zonmw, STW, VWS, Abbott, Medtronic, Saluda, Boston Scientific (Investigator initiated studies). LK: Consulting from Avanos, Institutional Funding from Avanos and FUS Mobile. RN: Dr North’s previous employers, including Johns Hopkins University, and the charitable nonprofit Neuromodulation Foundation, of which he is an unpaid officer, have received grant support and income from industry, including Abbott, Boston Scientific, Medtronic, Nevro, Algostim/Nuvectra, and Stimwave. He holds over 30 patents in the field of neuromodulation, and currently receives royalties from Abbott. SN: Editor for Reg Anesth Pain Med.
Similar articles
-
Role of patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain: a comprehensive narrative review.Reg Anesth Pain Med. 2023 Jun;48(6):251-272. doi: 10.1136/rapm-2022-103820. Epub 2023 Mar 30. Reg Anesth Pain Med. 2023. PMID: 37001887 Review.
-
Fantastic Four: Age, Spinal Cord Stimulator Waveform, Pain Localization and History of Spine Surgery Influence the Odds of Successful Spinal Cord Stimulator Trial.Pain Physician. 2020 Jan;23(1):E19-E30. Pain Physician. 2020. PMID: 32013285 Clinical Trial.
-
Comprehensive Evidence-Based Guidelines for Implantable Peripheral Nerve Stimulation (PNS) in the Management of Chronic Pain: From the American Society Of Interventional Pain Physicians (ASIPP).Pain Physician. 2024 Nov;27(S9):S115-S191. Pain Physician. 2024. PMID: 39565237
-
The impact of obesity on the effectiveness of spinal cord stimulation in chronic spine-related pain patients.Spine J. 2019 Mar;19(3):476-486. doi: 10.1016/j.spinee.2018.08.006. Epub 2018 Aug 22. Spine J. 2019. PMID: 30142457
-
Best Practices in Spinal Cord Stimulation.Spine (Phila Pa 1976). 2017 Jul 15;42 Suppl 14:S67-S71. doi: 10.1097/BRS.0000000000002220. Spine (Phila Pa 1976). 2017. PMID: 28459781 Review.
Cited by
-
Early epidural lead migration in spinal cord stimulator trials: A case series.Interv Pain Med. 2024 Jul 16;3(3):100426. doi: 10.1016/j.inpm.2024.100426. eCollection 2024 Sep. Interv Pain Med. 2024. PMID: 39502911 Free PMC article.
-
STIMFIX™ anchoring in percutaneous spinal cord stimulation trials: interim analysis of a multicenter study.Pain Manag. 2025 Aug;15(8):477-489. doi: 10.1080/17581869.2025.2527576. Epub 2025 Jul 8. Pain Manag. 2025. PMID: 40624980 Free PMC article. Clinical Trial.
-
Development and Feasibility Study of a Triage Tool for Early Referral to Spinal Cord Stimulation for Patients With Chronic Low Back and Leg Pain.Eur J Pain. 2025 Feb;29(2):e4780. doi: 10.1002/ejp.4780. Eur J Pain. 2025. PMID: 39757549 Free PMC article.
-
Wet Tap-Induced Spinal Cord Stimulator Trial Failure in Failed Back Surgery Syndrome: A Case Report Highlighting Intrathecal Drug Delivery for Treatment-Resistant Pain.Cureus. 2025 Jun 11;17(6):e85793. doi: 10.7759/cureus.85793. eCollection 2025 Jun. Cureus. 2025. PMID: 40656251 Free PMC article.
-
A Pragmatic Review on Spinal Cord Stimulation Therapy for Parkinson's Disease Gait Related Disorders: Gaps and Controversies.Mov Disord Clin Pract. 2024 Aug;11(8):927-947. doi: 10.1002/mdc3.14143. Epub 2024 Jun 20. Mov Disord Clin Pract. 2024. PMID: 38899557 Free PMC article.
References
-
- Deer TR, Mekhail N, Provenzano D, et al. The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the neuromodulation appropriateness consensus Committee. Neuromodulation: Technology at the Neural Interface 2014;17:515–50. - PubMed
-
- Katz N, Dworkin RH, North R, et al. Research design considerations for randomized controlled trials of spinal cord stimulation for pain: initiative on methods, measurement, and pain assessment in clinical trials/institute of neuromodulation/international neuromodulation Society recommendations. Pain 2021;162:1935–56. - PMC - PubMed
-
- Harmsen IE, Hasanova D, Elias GJB, et al. Trends in clinical trials for spinal cord stimulation. Stereotact Funct Neurosurg 2021;99:123–34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical